Skip to Content

5661 DAN (Sulindac 150 mg)

Pill with imprint 5661 DAN is Yellow, Round and has been identified as Sulindac 150 mg. It is supplied by Watson Laboratories, Inc..

Sulindac is used in the treatment of ankylosing spondylitis; bursitis; familial adenomatous polyposis; gout, acute; juvenile rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 5661 DAN

Sulindac 150 mg 5661 DAN
Sulindac 150 mg 5661 DAN Front
Sulindac 150 mg 5661 DAN Back
Sulindac 150 mg 5661 DAN

Sulindac

Imprint
5661 DAN
Strength
150 mg
Color
Yellow
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, stearic acid, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-5661 Watson Pharmaceuticals, Inc.
66267-0264 Nucare Pharmaceuticals Inc. (repackager)
54868-0879 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.